CoChat

Abnormal Glutamate Receptor Expression in the Medial Temporal Lobe in Schizophrenia and Mood Disorders

Beneyto, Monica, Kristiansen, Lars V, Oni-Orisan, Akinwunmi, McCullumsmith, Robert E, Meador-Woodruff, James H · 2007 · Neuropsychopharmacology

The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.

Abstract

Pharmacological and anatomical evidence suggests that abnormal glutamate neurotransmission may be associated with the pathophysiology of schizophrenia and mood disorders. Medial temporal lobe structural alterations have been implicated in schizophrenia and to a lesser extent in mood disorders. To comprehensively examine the ionotropic glutamate receptors in these illnesses, we used in situ hybridization to determine transcript expression of N-methyl-D-aspartate (NMDA), alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA), and kainate receptor subunits in the medial temporal lobe of subjects with schizophrenia, bipolar disorder (BD), or major depression (MDD). We used receptor autoradiography to assess changes in glutamate receptor binding in the same subjects. Our results indicate that there are region- and disorder-specific abnormalities in the expression of ionotropic glutamate receptor subunits in schizophrenia and mood disorders. We did not find any changes in transcript expression in the hippocampus. In the entorhinal cortex, most changes in glutamate receptor expression were associated with BD, with decreased GluR2, GluR3, and GluR6 mRNA expression. In the perirhinal cortex we detected decreased expression of GluR5 in all three diagnoses, of GluR1, GluR3, NR2B in both BD and MDD, and decreased NR1 and NR2A in BD and MDD, respectively. Receptor binding showed NMDA receptor subsites particularly affected in the hippocampus, where MK801 binding was reduced in schiz…

Overview

Integrity signals

Registry

Crossref · 10.1038/sj.npp.1301312

Cites

115 of 115 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 115 references

Cited by

See all 408

Metadata

Authors
Beneyto, M., Kristiansen, L. V., Oni-Orisan, A., McCullumsmith, R. E., & Meador-Woodruff, J. H.
Affiliations
University of Alabama at Birmingham (US)
Venue
Neuropsychopharmacology
Published
2007-02-14
Volume
32
Issue
9
Pages
1888-1902
ISSN
  • 0893-133X (ISSN-L)
  • 1740-634X
OpenAlex
W2024278554
Cited by
408
References
115
Citations by year
2026: 6 · 2025: 7 · 2024: 12 · 2023: 15 · 2022: 32 · 2021: 26 · 2020: 22 · 2019: 19 · 2018: 10 · 2017: 13 · 2016: 18 · 2015: 32 · 2014: 23 · 2013: 25 · 2012: 28
FWCI
16.31
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Neuropsychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Stanley Medical Research Institute
  • National Institute of Mental Health (MH 53327, R01MH053327)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Keywords
glutamate receptors, schizophrenia, bipolar disorder, major depressive disorder, mood disorders, medial temporal lobe, entorhinal cortex, perirhinal cortex, hippocampus, NMDA receptor, AMPA receptors, kainate receptors, receptor binding, glutamatergic neurotransmission, synaptic transmission
MeSH terms
Adult, Analysis of Variance, Autoradiography, Female, Gene Expression Regulation, Humans, Indoles, Male, Middle Aged, Postmortem Changes, Protein Binding, Schizophrenia, Temporal Lobe, 2-Amino-5-phosphonovalerate, In Situ Hybridization, Receptors, Glutamate, Excitatory Amino Acid Antagonists, Mood Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Abnormal Glutamate Receptor Expression in the Medial Temporal Lobe in Schizophrenia and Mood Disorders. https://app.cochat.ai/papers/10.1038/sj.npp.1301312
The paper
Beneyto, M., Kristiansen, L. V., Oni-Orisan, A., McCullumsmith, R. E., & Meador-Woodruff, J. H. (2007). Abnormal Glutamate Receptor Expression in the Medial Temporal Lobe in Schizophrenia and Mood Disorders. Neuropsychopharmacology. https://doi.org/10.1038/sj.npp.1301312

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.